Isis Pharma (ISIS) – Insiders' Blog
-
Risk/Reward for Isis Pharma (ISIS) is Sinking Fast - Barron's
-
ISIS Pharmaceuticals (ISIS) Hit Following Two-Notch Analyst Downgrade
-
'Takeover Fever' Continues In Biotech After Facet (FACT) Deal, Who's Next?
-
Analysts Thoughts On Isis Pharmaceuticals (ISIS) After 19% Sell-Off
-
Following Today's Kosan (KOSN) Buyout, Investors Look for Next Biotech Deal
Back to ISIS Stock Lookup